Author: Xu Jing Wei Qichun
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.22, Iss.12, 2012-12, pp. : 1485-1487
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Use of Therapeutic Peptides to Target and to Kill Cancer Cells
Current Medicinal Chemistry, Vol. 19, Iss. 22, 2012-08 ,pp. :
Polymyxin derivatives: a patent evaluation (WO2012168820)
By Wu Haifan
Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. :
Therapeutic compounds: patent evaluation of WO2011011652A1
Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. :